SPH Notice - Kauri NZ Investment Limited (“Kauri NZ”)

1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
To NZX Limited (NZX)
and
To Comvita Limited (NZX: CVT) (“CVT”)
Relevant event being disclosed: Movement of 1% or more in substantial holding
Date of relevant event: 18 May 2026
Date this disclosure made: 19 May 2026
Date last disclosure made: 17 April 2026
Substantial product holder(s) giving disclosure
Full name(s): Kauri NZ Investment Limited (“Kauri NZ”)
Summary of substantial holding
Class of quoted voting products: Ordinary shares in CVT (ISIN: NZCVTE0001S7)
Summary for Kauri NZ
For this disclosure,—
(a)total number held in class: 13,173,880
(b)total in class: 129,839,035
(c)total percentage held in class: 10.146%
For last disclosure,—
(a)total number held in class: 7,966,813
(b)total in class: 70,561,746
(c)total percentage held in class: 11.291%
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure: On 18 May 2026, CVT
issued 5,207,067 fully paid ordinary shares to Kauri NZ for $0.65 per ordinary share under
the capital raising announced by CVT on 15 April 2026. As a result of the capital raising,
there has been a dilution in Kauri NZ’s interest in CVT.
Details after relevant event
Details for Kauri NZ
Nature of relevant interest(s): Registered holder and beneficial owner of ordinary shares
in CVT.

2
For that relevant interest,—
(a)number held in class: 13,173,880
(b)percentage held in class: 10.146%
(c)current registered holder(s): Kauri NZ
(d)registered holder(s) once transfers are registered: Not applicable
For a derivative relevant interest, also—
(a)type of derivative: Not applicable
(b)details of derivative: Not applicable
(c)if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: Not applicable
Additional information
Address(es) of substantial product holder(s): Level 3, 139 Quay Street, Auckland Central,
1010, New Zealand
Contact details: Julia Xu, julia.xu@oravida.com, +64 9 379 7308
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: Not applicable
Certification
I, Julia Xu, certify that, to the best of my knowledge and belief, the information contained
in this disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.